Sageworth Trust CO Gilead Sciences, Inc. Transaction History

Sageworth Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $496 - $624	-8 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $578 - $672	8 New	8 $1,000
Q1 2019 Apr 08, 2019	SELL	$62.53 - $70.05 $500 - $560	-8 Closed	0 $0
Q4 2018 Jan 18, 2019	BUY	$60.54 - $79.0 $484 - $632	8 New	8 $1,000
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $9,472 - $11,049	-146 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $10,634 - $12,964	146 New	146 $11,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

Stay updated on Sageworth Trust CO with notifications on news.